论文部分内容阅读
目的:门冬氨酸钾镁在胃肠疾病所指低钾血症患者中的临床治疗效果。方法:选取我院于2013年1月-2016年6月间收治的60例因胃肠疾病所致低钾血症患者,随机将其分为观察组、对照组,其中观察组患者30例,接受门冬氨酸钾镁治疗;对照组患者30例,接受常规治疗,比较两组患者治疗效果。结果:在本次研究中,观察组患者血钾浓度恢复正常的时间明显短于对照组[(2.3±0.9)d VS(3.7±1.4)d,P<0.05]。结论:门冬氨酸钾镁在肠胃疾病所致的低钾血症患者治疗中发挥着重要作用,有助于改善患者临床症状,为保证预后奠定良好基础,应该在临床上做进一步推广。
Aims: The clinical effects of potassium magnesium aspartate in patients with hypokalemia referred to by gastrointestinal diseases. Methods: Sixty patients with hypokalemia due to gastrointestinal diseases were enrolled in our hospital from January 2013 to June 2016. They were randomly divided into observation group, control group, 30 cases in observation group, Received aspartate magnesium and magnesium treatment; control group of 30 patients, receiving conventional treatment, the treatment effect of two groups were compared. Results: In this study, the observation group patients with serum potassium concentration returned to normal was significantly shorter than the control group [(2.3 ± 0.9) d VS (3.7 ± 1.4) d, P <0.05]. Conclusion: Potassium magnesium aspartate plays an important role in the treatment of patients with hypokalemia caused by gastrointestinal diseases, which can help to improve the clinical symptoms of patients and lay a good foundation for prognosis. It should be further popularized clinically.